Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,278 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Study of a New MVA Vaccine for Hepatitis C Virus

NCT01296451

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
  • Wycombe Hospital, High Wycombe, Buckinghamshire High Wycombe, United Kingdom
View Trial Details
Completed

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

NCT01825031

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Moi University Clinical Research Centre Eldoret, Kenya
  • KEMRI Wellcome Trust Research Programme Kilifi, Kenya
  • University of Malawi Blantyre, Malawi
  • Joint Clinical Research Centre, Fort Portal Fort Portal, Uganda
View Trial Details
Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

NCT01970904

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Düsseldorf, Germany
View all 25 locations
View Trial Details
Completed

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

NCT00905632

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.7.3307A CHU de Grenoble Grenoble Cédex 9, France
  • 1241.7.3303A Hôpital Claude Huriez Lille, France
  • 1241.7.3302A Hopital de l'Hotel Dieu Lyon, France
  • 1241.7.3301A Hôpital Saint Eloi Montpellier, France
View all 18 locations
View Trial Details
Completed

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

NCT01732796

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.20.00026 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States
  • 1241.20.00033 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
  • 1241.20.00006 Boehringer Ingelheim Investigational Site La Mesa, California, United States
  • 1241.20.00003 Boehringer Ingelheim Investigational Site Oceanside, California, United States
View all 101 locations
View Trial Details
Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

NCT00077649

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • La Jolla, California, United States
  • Long Beach, California, United States
  • San Diego, California, United States
  • San Diego, California, United States
View all 25 locations
View Trial Details

Related conditions